⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL62738 | 1.00 | — | — | |
| SCHEMBL8592894 | 1.00 | CA1 (0.47) | — | |
| SCHEMBL594228 | 1.00 | — | — | |
| SCHEMBL359648 | 1.00 | — | — | |
| SCHEMBL7404513 | 1.00 | — | — | |
| SCHEMBL13739602 | 1.00 | — | — | |
| Bromide SCHEMBL11804569 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL18074836 | 0.95 | — | — | |
| SCHEMBL1668954 | 0.91 | CA1 (0.50) | — | |
| SCHEMBL379845 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118240233-A | Functionalized polymer grafted functionalized nano material composite modifier, modified asphalt and application thereof in coating waterproofing | 苏州非特兄弟新材料科技有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-118063784-A | Nano material grafted block copolymer composite modified asphalt and waterproof application | 苏州非特兄弟新材料科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| US-20230190883-A1 | STABLE PEPTIDES HAVING RENALASE AGONIST ACTIVITY | PERSONAL THERAPEUTICS, LLC | 2023-06-22 | — | — | US | claimed |
| CN-116157140-A | Stable peptides with renal enzymatic agent activity | 贝索制药有限责任公司 | 2023-05-23 | — | — | CN | claimed |
| CN-109336887-B | Benzimidazole chiral heterocyclic compound and preparation method and application thereof | 中山大学 | 2021-12-17 | — | — | CN | claimed |
| CN-106831862-B | Chiral bridged axial chiral monophosphine ligand and preparation method thereof | 中山大学 | 2021-01-15 | — | — | CN | claimed |
| EP-3658701-A1 | PROCESS FOR THE PREPARATION OF METALLIC NANO-PARTICLE LAYERS AND THEIR USE FOR DECORA-TIVE OR SECURITY ELEMENTS | BASF SE (DE) | 2020-06-03 | — | — | EP | claimed |
| CN-110832110-A | Method for producing a metal nanoparticle layer and use thereof in decorative or security elements | 巴斯夫欧洲公司 | 2020-02-21 | — | — | CN | claimed |
| US-10336668-B2 | Method for producing cis- and trans-enriched MDACH | BASF SE (DE) | 2019-07-02 | — | — | US | claimed |
| WO-2019020682-A1 | PROCESS FOR THE PREPARATION OF METALLIC NANO-PARTICLE LAYERS AND THEIR USE FOR DECORA-TIVE OR SECURITY ELEMENTS | BASF SE (DE) | 2019-01-31 | — | — | WO | claimed |
| US-6642170-B1 | Metals selected from tantalum, vanadium, niobium, chromium, molybdenum or tungsten on catalyst supports such as zeolites, oxides of silicon, aluminum, titanium, titanium, niobium or tantalum, used for etherification of alcohols-2+ | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2003-11-04 | — | — | US | claimed |
| EP-0957903-A4 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS INC (US) | 2002-10-09 | — | — | EP | claimed |
| US-20020141952-A1 | Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues | APPLIED GENETICS INCORPORATED DERMATICS | 2002-10-03 | — | — | US | claimed |
| WO-2002051395-A1 | TREATMENT OF NEURODEGENERATIVE DISEASES | CODON PHARMACEUTICALS, INC. (US) | 2002-07-04 | — | — | WO | claimed |
| EP-1109623-A1 | NOVEL SOLID OXIDATION CATALYSTS, IN PARTICULAR FOR EPOXIDATION OF PROCHIRAL COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2001-06-27 | — | — | EP | claimed |
| WO-2000003802-A1 | NOVEL SOLID OXIDATION CATALYSTS, IN PARTICULAR FOR EPOXIDATION OF PROCHIRAL COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2000-01-27 | — | — | WO | claimed |
| EP-0957903-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | Codon Pharmaceuticals, Inc. (US) | 1999-11-24 | — | — | EP | claimed |
| US-5990177-A | CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM | CODON PHARMACEUTICALS, INC. (US) | 1999-11-23 | — | — | US | claimed |
| WO-1998055085-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-12-10 | — | — | WO | claimed |
| WO-1998011882-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-03-26 | — | — | WO | claimed |